Wells Fargo’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wells Fargo’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-750,000	Closed	-$75.2M	–	7382
2025 Q3	$75.2M	Buy	+750,000	New	+$67.6M	0.01%	722
2022 Q3	–	Sell	-25,000	Closed	-$1.86M	–	7481
2022 Q2	$1.86M	Sell	25,000 -15,000	-38%	-$1.13M	﹤0.01%	2859
2022 Q1	$3.6M	Buy	+40,000	New	+$3.69M	﹤0.01%	2751
2021 Q2	–	Sell	-173,700	Closed	-$23.6M	–	7529
2021 Q1	$23.6M	Buy	+173,700	New	+$26M	0.01%	1539

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo's XBI Position: Q2 2026 in Review

Wells Fargo increased its State Street SPDR S&P Biotech ETF (XBI) stake by 28% in Q2 2026, buying an estimated $102M and bringing the position to 3,504,082 shares worth $555M. The position accounts for 0.09% of the portfolio, ranked #199.

Wells Fargo first reported a position in XBI in Q2 2013 and has held it in 53 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Wells Fargo held 3,504,082 shares of State Street SPDR S&P Biotech ETF worth $555M as of Q2 2026.
Wells Fargo bought 757,873 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $102M.
State Street SPDR S&P Biotech ETF made up 0.09% of Wells Fargo's portfolio in Q2 2026, its #199 holding.
Wells Fargo first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 53 quarters since.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.